a phase II study of chemoradiotherapy with CDDP+5-FU+DOC for postoperaitve loco-regional recurrent esophageal cancer
Phase 2
- Conditions
- postoperative loco-regional recurrent esophageal cancer
- Registration Number
- JPRN-UMIN000019269
- Lead Sponsor
- Tohoku university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1) with distant organ metastasis 2) with irradaiation history 3) recurrence after EMR 4) second primary 5) double active cancer 6) with severe complication 7) pregant female 8) active infection 9) regular use steroid 10) with pace maker or implantable cardioverter defibrillator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method progression-free survival, toxicity